Suppr超能文献

[RhD阴性女性RhD同种免疫预防指南]

[Guideline for prevention of RhD alloimmunizationin RhD negative women].

作者信息

Lubušký M, Procházka M, Simetka O, Holusková I

机构信息

Porodnicko-gynekologická Klinika LF UP a FN, Olomouc, Prednosta prof. MUDr. R. Pilka, PhD.

出版信息

Ceska Gynekol. 2013 Apr;78(2):132-3.

Abstract

Events following which immunoglobulin (Ig) G anti-D should be given to all RhD negative women with no anti-D alloantibodies: First trimester indications (IgG anti-D sufficient dose of 50 μg*) - termination of pregnancy, spontaneous abortion followed by instrumentation, ectopic pregnancy, chorionic villus sampling, partial molar pregnancy; Second and third trimester indications (IgG anti-D sufficient dose of 100 μg*) - amniocentesis, cordocentesis, other invasive prenatal diagnostic or therapeutic procedures, spontaneous or induced abortion, intrauterine fetal death, attempt at external cephalic version of a breech presentation, abdominal trauma, obstetric hemorrhage; Antenatal prophylaxis at 28th weeks of gestation (IgG anti-D sufficient dose of 250 μg*); Delivery of an RhD positive infant** (IgG anti-D sufficient dose of 100 μg*); Minimal dose*: before 20 weeks gestation - 50 μg (250 IU), after 20 weeks gestation*** - 100 μg (500 IU); Timing: as soon as possible, but no later than 72 hours after the event. In cases where prevention of RhD alloimmunization is not performed within 72 hours of a potentially sensitising event, it is still reasonable to administer IgG anti-D within 13 days, and in special cases, administration is still recommended up to a maximum interval of 28 days postpartum; Legend: *administration of a higher dose of IgG anti-D is not a mistake, ** also if the D type is not known, *** simultaneous assessment of the volume of fetomaternal hemorrhage (FMH) to specify the dose is suitable; The FMH volume assessment - If the volume of fetal erythrocytes (red bood cells, RBCs) which entered maternal circulation is assessed, intramuscular administration of IgG anti-D in a dose of 10 μg per 0.5 mL of fetal RBCs or 1 mL of whole fetal blood is indicated. IgG anti-D in a dose of 10 μg administered intramuscularly should cover 0.5 mL of fetal RhD positive RBCs or 1mL of whole fetal blood. FMH is the fetal RBC volume; fetal blood volume is double (expected fetal hematocrit is 50%).

摘要

所有RhD阴性且无抗D同种抗体的女性应给予免疫球蛋白(Ig)G抗-D的情况:孕早期指征(IgG抗-D足量剂量为50μg*)——终止妊娠、自然流产后行清宫术、异位妊娠、绒毛取样、部分性葡萄胎;孕中期和孕晚期指征(IgG抗-D足量剂量为100μg*)——羊膜腔穿刺术、脐血穿刺术、其他侵入性产前诊断或治疗操作、自然流产或人工流产、胎儿宫内死亡、臀位外倒转术尝试、腹部创伤、产科出血;妊娠28周时的产前预防(IgG抗-D足量剂量为250μg*);分娩RhD阳性婴儿**(IgG抗-D足量剂量为100μg*);最小剂量*:妊娠20周前——50μg(250IU),妊娠20周后***——100μg(500IU);给药时间:尽快,但不迟于事件发生后72小时。在潜在致敏事件发生后72小时内未进行RhD同种免疫预防的情况下,在13天内给予IgG抗-D仍属合理,特殊情况下,产后最长间隔28天仍建议给药;说明:*给予更高剂量的IgG抗-D并非错误,**即使D血型未知,***同时评估母胎输血(FMH)量以确定合适剂量为宜;FMH量评估——如果评估进入母体循环的胎儿红细胞(红细胞,RBC)量,每0.5mL胎儿RBC或1mL全胎儿血肌肉注射10μg剂量的IgG抗-D。肌肉注射10μg剂量的IgG抗-D应覆盖0.5mL胎儿RhD阳性RBC或1mL全胎儿血。FMH即胎儿RBC量;胎儿血量为其两倍(预期胎儿血细胞比容为50%)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验